Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.

Détails

Ressource 1Télécharger: 2023-Editorial_Frontiers_PE-HTA.pdf (540.14 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_1C74847FFDC9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
UNIL/CHUV
Titre
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.
Périodique
Frontiers in pharmacology
Auteur⸱e⸱s
Girardin F.R., Cohen K., Schwenkglenks M., Durand-Zaleski I.
ISSN
1663-9812 (Print)
ISSN-L
1663-9812
Statut éditorial
Publié
Date de publication
2023
Peer-reviewed
Oui
Volume
14
Pages
1210002
Langue
anglais
Notes
Publication types: Editorial
Publication Status: epublish
Mots-clé
Pharmacology (medical), Pharmacology, cost-effectiveness, disinvestment choices, health technology assessment (HTA), patient related outcome, pharmacoeconomics
URN
urn:nbn:ch:serval-BIB_1C74847FFDC93
OAI-PMH
oai:serval.unil.ch:BIB_1C74847FFDC9
DOI
10.3389/fphar.2023.1210002
Pubmed
37261286
Web of science
000999302400001
Open Access
Oui
Création de la notice
31/05/2023 8:43
Dernière modification de la notice
15/06/2023 5:56
Données d'usage